1. Home
  2. HRTG vs OMER Comparison

HRTG vs OMER Comparison

Compare HRTG & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Insurance Holdings Inc.

HRTG

Heritage Insurance Holdings Inc.

HOLD

Current Price

$24.63

Market Cap

898.0M

Sector

Finance

ML Signal

HOLD

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$11.93

Market Cap

894.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRTG
OMER
Founded
2012
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
898.0M
894.8M
IPO Year
2014
2009

Fundamental Metrics

Financial Performance
Metric
HRTG
OMER
Price
$24.63
$11.93
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$32.50
$32.50
AVG Volume (30 Days)
242.0K
1.4M
Earning Date
03-10-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
98.61
N/A
EPS
4.83
N/A
Revenue
$842,277,000.00
N/A
Revenue This Year
$5.45
N/A
Revenue Next Year
$7.27
N/A
P/E Ratio
$5.14
N/A
Revenue Growth
6.12
N/A
52 Week Low
$9.89
$2.95
52 Week High
$31.98
$17.65

Technical Indicators

Market Signals
Indicator
HRTG
OMER
Relative Strength Index (RSI) 37.01 50.35
Support Level $24.23 $11.00
Resistance Level $25.87 $11.46
Average True Range (ATR) 1.02 0.60
MACD -0.07 -0.00
Stochastic Oscillator 21.71 60.45

Price Performance

Historical Comparison
HRTG
OMER

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: